Which US state Medicaid programs cover Wegovy, Zepbound, or Saxenda for adult obesity in 2026? Color-coded tile map, sortable per-state table, BMI thresholds, prior-authorization criteria, and the coverage growth trend since 2022. Updated quarterly.
12
States covering Wegovy/Zepbound for obesity
5
States with partial / restrictive coverage
~38%
US Medicaid population with weight-loss GLP-1 access
+9
Net states added obesity coverage since 2022
Coverage map
Click a state for prior-authorization criteria, BMI thresholds, and the specific GLP-1 medications covered. Tile positions are approximately geographic.
State Medicaid GLP-1 obesity coverage 2026 (tile map)
Sources: KFF Medicaid GLP-1 brief, state Medicaid PDLs, and direct state-program disclosures. Coverage status varies by individual plan within state managed-care organizations; tile reflects the modal coverage. Verified 2026-04-27.
Coverage growth: 2022 → 2026
The number of state Medicaid programs covering weight-loss GLP-1s for obesity has grown from approximately 3 in 2022 to 12 in 2026.
US states with Medicaid weight-loss GLP-1 obesity coverage, 2022-2026
Source: aggregated from KFF Medicaid GLP-1 issue briefs, state PDL update logs. The trend reflects rising legislative pressure and acknowledgment that obesity is a covered medical condition under state Medicaid plans.
Coverage by state (2026)
Click any column header to sort. Population figures from US Census 2024 estimates; “Medicaid enrollees” reflect 2024 KFF data.
| State | Coverage status | BMI threshold | Drugs covered (obesity) | Prior auth notes |
|---|
Coverage criteria comparison
For the 12 states that cover, the eligibility criteria differ significantly. The most common gatekeepers: BMI threshold (typically 30 or 35), documented failed lifestyle intervention, and ongoing behavioral counseling.
Coverage gatekeeper criteria across states with obesity coverage
Source: aggregated from state Medicaid Preferred Drug Lists. Counts approximate the 12 states with confirmed obesity coverage; criteria overlap (most states use 2-4 criteria).
How to check your state’s coverage
If your state’s data is incomplete or out of date here, the canonical source is your state’s Medicaid Preferred Drug List (PDL) — usually a downloadable PDF on your state’s department of health website. Three quick paths:
- Search your state’s name + “Medicaid Preferred Drug List” + “2026”
- Call your Medicaid plan’s pharmacy benefits help line (the number on your card)
- Ask your prescriber to submit a prior-authorization request — denial reasons usually cite the specific PDL clause
Coverage of T2D-indicated GLP-1s (Ozempic, Mounjaro, Trulicity, Victoza, Bydureon) is broader than weight-loss coverage in nearly every state — those drugs are typically covered with a documented type 2 diabetes diagnosis.
